Agilent Technologies, Inc. $A Shares Sold by ING Groep NV

ING Groep NV decreased its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 36.7% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 16,747 shares of the medical research company’s stock after selling 9,691 shares during the period. ING Groep NV’s holdings in Agilent Technologies were worth $2,149,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also recently added to or reduced their stakes in A. Brighton Jones LLC grew its position in shares of Agilent Technologies by 6.1% in the fourth quarter. Brighton Jones LLC now owns 4,663 shares of the medical research company’s stock valued at $626,000 after purchasing an additional 270 shares during the period. Jones Financial Companies Lllp increased its stake in Agilent Technologies by 15.9% during the 1st quarter. Jones Financial Companies Lllp now owns 5,610 shares of the medical research company’s stock worth $602,000 after buying an additional 769 shares in the last quarter. Geneos Wealth Management Inc. raised its holdings in shares of Agilent Technologies by 54.8% during the first quarter. Geneos Wealth Management Inc. now owns 599 shares of the medical research company’s stock valued at $70,000 after acquiring an additional 212 shares during the last quarter. Acadian Asset Management LLC raised its holdings in shares of Agilent Technologies by 16.5% during the first quarter. Acadian Asset Management LLC now owns 5,352 shares of the medical research company’s stock valued at $625,000 after acquiring an additional 758 shares during the last quarter. Finally, Sivia Capital Partners LLC purchased a new position in shares of Agilent Technologies in the second quarter valued at approximately $273,000.

Agilent Technologies Trading Up 0.7%

A opened at $125.80 on Friday. The company has a market cap of $35.58 billion, a P/E ratio of 27.53, a PEG ratio of 3.63 and a beta of 1.30. Agilent Technologies, Inc. has a one year low of $96.43 and a one year high of $160.27. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.52 and a current ratio of 1.96. The business’s 50-day simple moving average is $137.84 and its 200-day simple moving average is $135.30.

Agilent Technologies (NYSE:A) last issued its quarterly earnings data on Monday, November 24th. The medical research company reported $1.59 earnings per share for the quarter, topping the consensus estimate of $1.58 by $0.01. Agilent Technologies had a net margin of 18.75% and a return on equity of 25.20%. The business had revenue of $1.86 billion during the quarter, compared to the consensus estimate of $1.83 billion. During the same quarter in the previous year, the firm earned $1.46 EPS. The company’s revenue was up 9.4% compared to the same quarter last year. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS and its FY 2026 guidance at 5.860-6.000 EPS. As a group, equities research analysts expect that Agilent Technologies, Inc. will post 5.58 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 22nd. Shareholders of record on Tuesday, March 31st will be paid a $0.255 dividend. The ex-dividend date is Tuesday, March 31st. This represents a $1.02 dividend on an annualized basis and a yield of 0.8%. Agilent Technologies’s payout ratio is currently 22.32%.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on A. Citigroup lifted their target price on shares of Agilent Technologies from $165.00 to $185.00 and gave the stock a “buy” rating in a research note on Tuesday, November 25th. Robert W. Baird raised their target price on Agilent Technologies from $142.00 to $165.00 and gave the stock an “outperform” rating in a research note on Tuesday, November 25th. Wells Fargo & Company upped their target price on shares of Agilent Technologies from $150.00 to $175.00 and gave the company an “overweight” rating in a research report on Tuesday, November 25th. JPMorgan Chase & Co. increased their price objective on shares of Agilent Technologies from $165.00 to $180.00 and gave the stock an “overweight” rating in a research report on Tuesday, November 25th. Finally, Evercore upgraded shares of Agilent Technologies from an “in-line” rating to an “outperform” rating and boosted their price target for the stock from $155.00 to $160.00 in a research note on Monday, January 5th. Two investment analysts have rated the stock with a Strong Buy rating, eleven have issued a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $164.50.

Insiders Place Their Bets

In related news, CEO Padraig Mcdonnell sold 911 shares of the stock in a transaction on Tuesday, November 18th. The shares were sold at an average price of $143.24, for a total transaction of $130,491.64. Following the completion of the sale, the chief executive officer owned 32,058 shares in the company, valued at $4,591,987.92. This represents a 2.76% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, VP Rodney Gonsalves sold 3,000 shares of the firm’s stock in a transaction dated Wednesday, November 26th. The stock was sold at an average price of $154.99, for a total value of $464,970.00. Following the transaction, the vice president directly owned 31,846 shares in the company, valued at approximately $4,935,811.54. This represents a 8.61% decrease in their position. The SEC filing for this sale provides additional information.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.